Submitted by Anonymous (not verified) on 17 October 2024 - 10:28
Human medicines European public assessment report (EPAR): Gefitinib Mylan, gefitinib, Date of authorisation: 27/09/2018, Revision: 7, Status: Withdrawn (authorisation)
Source: